Impact of a Prescription Produce Program on Diabetes and Cardiovascular Risk Outcomes

To evaluate the impact of a fruit and vegetable prescription program on diabetes and cardiovascular risk outcomes. Single-arm pre-post study. Primary care clinic in a community-based hospital. Adults with type 2 diabetes (n = 97), aged > 18 years, with hemoglobin A1c (HbA1c) ≥ 7.0%, and a body ma...

Full description

Saved in:
Bibliographic Details
Published inJournal of nutrition education and behavior Vol. 53; no. 12; pp. 1008 - 1017
Main Authors Veldheer, Susan, Scartozzi, Christina, Bordner, Candace R., Opara, Chinwendu, Williams, Brittany, Weaver, Lisa, Rodriguez, Diana, Berg, Arthur, Sciamanna, Christopher
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To evaluate the impact of a fruit and vegetable prescription program on diabetes and cardiovascular risk outcomes. Single-arm pre-post study. Primary care clinic in a community-based hospital. Adults with type 2 diabetes (n = 97), aged > 18 years, with hemoglobin A1c (HbA1c) ≥ 7.0%, and a body mass index (BMI) of ≥ 25 kg/m2. Over 7 months, participants received monthly group-based diabetes self-management education (DSME) and monthly vouchers ($28–$140/month) redeemable for fruits and vegetables at local markets. Biomarker changes (HbA1c, BMI, and blood pressure) were assessed with paired t tests. Voucher distribution and redemption were tracked, and voucher redemption rates were calculated. Linear mixed-effect regression models tested associations between biomarkers, voucher redemption rates, and participant characteristics. There was a −1.3% (P < 0.001) postprogram change in HbA1c. Reduced HbA1c was associated with higher voucher redemption rates (P = 0.032) and a change in diabetes medications (P = 0.003). There were no associations with BMI, but blood pressure was positively associated with voucher redemption. Fruit and vegetable prescription programs may improve diabetes outcomes by incentivizing DSME uptake and retention. Future randomized trials are warranted to identify strategies to improve DSME engagement and voucher redemption rates and assess mechanisms through which these programs influence health outcomes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1499-4046
1878-2620
1878-2620
DOI:10.1016/j.jneb.2021.07.005